Literature DB >> 19221341

Insulin analogues: too much noise about small benefits.

Andrea Siebenhofer-Kroitzsch1, Karl Horvath, Johannes Plank.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19221341      PMCID： PMC2638050          DOI： 10.1503/cmaj.081962

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  Insulin glulisine imparts effective glycaemic control in patients with Type 2 diabetes.

Authors:  Gerrard Rayman; Velimir Profozic; Michelle Middle
Journal:  Diabetes Res Clin Pract       Date:  2006-11-20       Impact factor: 5.602

2.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

Review 3.  Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

Authors:  A Siebenhofer; J Plank; A Berghold; K Jeitler; K Horvath; M Narath; R Gfrerer; T R Pieber
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

4.  Do insulin-treated diabetic patients use an injection-meal-interval in daily life?

Authors:  L Heinemann
Journal:  Diabet Med       Date:  1995-05       Impact factor: 4.359

5.  Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study.

Authors:  A Sämann; I Mühlhauser; R Bender; Ch Kloos; U A Müller
Journal:  Diabetologia       Date:  2005-08-18       Impact factor: 10.122

6.  A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.

Authors:  E A Gale
Journal:  Diabet Med       Date:  2000-03       Impact factor: 4.359

7.  Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up.

Authors:  J Plank; G Köhler; I Rakovac; B M Semlitsch; K Horvath; G Bock; B Kraly; T R Pieber
Journal:  Diabetologia       Date:  2004-07-17       Impact factor: 10.122

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial.

Authors: 
Journal:  BMJ       Date:  2002-10-05

10.  Evaluation of a structured teaching and treatment programme for type 2 diabetes in general practice in a rural area of Austria.

Authors:  T R Pieber; A Holler; A Siebenhofer; G A Brunner; B Semlitsch; S Schattenberg; H Zapotoczky; W Rainer; G J Krejs
Journal:  Diabet Med       Date:  1995-04       Impact factor: 4.359
View more
  1 in total

1.  Effectiveness and safety of insulin glargine versus detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis.

Authors:  Thales B C Silva; Paulo H R F Almeida; Vania E Araújo; Francisco de Assis Acurcio; Augusto A Guerra Júnior; Brian Godman; Juliana Alvares
Journal:  Ther Adv Endocrinol Metab       Date:  2018-06-22       Impact factor: 3.565
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.